Cliff Asness's TYRA Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 29,423 shares of Tyra Biosciences, Inc. (TYRA) worth $1.13 M, representing 0.00% of the portfolio. First purchased in 2025-Q2, this short-term holding has been held for 4 quarters.
Based on 13F filings, Cliff Asness has maintained this position in TYRA for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 792 shares. Largest reduction occurred in Q3 2025, reducing 643 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Tyra Biosciences (TYRA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Tyra Biosciences (TYRA) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +792 | Add 2.77% | 29,423 | $38.30 |
| Q4 2025 | +562 | Add 2.00% | 28,631 | $26.29 |
| Q3 2025 | -643 | Reduce 2.24% | 28,069 | $13.99 |
| Q2 2025 | +28,712 | New Buy | 28,712 | $9.57 |
Cliff Asness's Tyra Biosciences Investment FAQs
Cliff Asness first purchased Tyra Biosciences, Inc. (TYRA) in Q2 2025, acquiring 28,712 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Tyra Biosciences, Inc. (TYRA) for 4 quarters since Q2 2025.
Cliff Asness's largest addition to Tyra Biosciences, Inc. (TYRA) was in Q2 2025, adding 28,712 shares worth $274,774.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 29,423 shares of Tyra Biosciences, Inc. (TYRA), valued at approximately $1.13 M.
As of the Q1 2026 filing, Tyra Biosciences, Inc. (TYRA) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Tyra Biosciences, Inc. (TYRA) was 29,423 shares, as reported at the end of Q1 2026.